ACAT1 and neoplasm: In addition, our finding that human PD-1hiCD28lo CD8+ T cells have reduced lipid microdomain staining, and that this serves as a predictor of response to ACAT inhibition, raises the possibility that ACAT will be a tractable metabolic checkpoint in other disease settings characterised by exhausted T cells, including other chronic viral infections and tumours.